Kensey Nash Touts Prospects For TriActiv Embolic Protection Device
This article was originally published in The Gray Sheet
Executive Summary
Kensey Nash believes the embolic protection market for saphenous vein graft procedures will double to more than $200 mil. in the next few years as physicians use distal protection to diminish their exposure to litigation